{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:06Z","timestamp":1786991466436,"version":"build-2736575974"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.japh.2023.12.018","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T10:43:16Z","timestamp":1703500996000},"page":"101999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0746-5141","authenticated-orcid":false,"given":"Mallory","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-4331","authenticated-orcid":false,"given":"Miranda","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-5671","authenticated-orcid":false,"given":"Kelly","family":"Houck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2023.12.018_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2022"},{"key":"10.1016\/j.japh.2023.12.018_bib2","series-title":"Opioid Use Disorder","author":"Dydyk","year":"2022"},{"key":"10.1016\/j.japh.2023.12.018_bib3","series-title":"Clinical practice guideline for the management of substance use disorders","year":"2021"},{"key":"10.1016\/j.japh.2023.12.018_bib4","author":"Hedegaard"},{"issue":"3","key":"10.1016\/j.japh.2023.12.018_bib6","first-page":"153","article-title":"A\u00a0systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.japh.2023.12.018_bib8","unstructured":"Department of Veteran Affairs. Assistant under secretary for health for clinical services\/Chief Medical Officer. Naloxone distribution to veterans diagnosed with opioid use disorder (OUD). Published\u00a02021."}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123004302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319123004302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T21:05:57Z","timestamp":1736283957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319123004302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1544319123004302"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.12.018","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"101999"}}